Related references
Note: Only part of the references are listed.Green Synthesis of Nano Hydroxyapatite: morphology variation and its effect on cytotoxicity against fibroblast
Andrea Elizabeth Melgar Aguilar et al.
MATERIALS LETTERS (2021)
Rhein-PEG-nHA conjugate as a bone targeted drug delivery vehicle for enhanced cancer chemoradiotherapy
Xiuying Yang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Zoledronic Acid-containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor
Xu Li et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Click on PLGA-PEG and hyaluronic acid: Gaining access to anti-leishmanial pentamidine bioconjugates
Angela Scala et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2018)
One pot synthesis of carbon dots decorated carboxymethyl cellulose-hydroxyapatite nanocomposite for drug delivery, tissue engineering and Fe3+ ion sensing
Chandrani Sarkar et al.
CARBOHYDRATE POLYMERS (2018)
CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells
Tang Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Zoledronic Acid: Pleiotropic Anti-tumor Mechanism and Therapeutic Outlook for Osteosarcoma
Zhengxiao Ouyang et al.
CURRENT DRUG TARGETS (2018)
Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior
Catarina Santos et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
A hyaluronic acid binding peptide-polymer system for treating osteoarthritis
Heather J. Faust et al.
BIOMATERIALS (2018)
Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations
Shweta Pandey et al.
PHARMACEUTICAL RESEARCH (2018)
Nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG containing curcumin: In vitro evaluation and pharmacokinetics in rats
Yurui Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Morphology effect of nano-hydroxyapatite as a drug carrier of methotrexate
Haina Sun et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2017)
Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic
Kin Man Au et al.
BIOMATERIALS (2016)
Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations
Samira Jafari et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
CD44: More than a mere stem cell marker
I. Morath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Synthesis of nanostructured methotrexate/hydroxyapatite: Morphology control, growth mechanism, and bioassay explore
Chao-Fan Dai et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Osteosarcoma treatment - Where do we stand? A state of the art review
Anja Luetke et al.
CANCER TREATMENT REVIEWS (2014)
Nano-Hydroxyapatite Composite Biomaterials for Bone Tissue Engineering-A Review
Jayachandran Venkatesan et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Emulsion cross-linked chitosan/nanohydroxyapatite microspheres for controlled release of alendronate
Hongwei Wu et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2014)
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
Wenyi Gu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity
Hilary Shmeeda et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Biomedical applications of bisphosphonates
Elisabeth V. Giger et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2
Masanobu Tsubaki et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Bisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG-63 human osteosarcoma cells
Jun Chang et al.
ONCOLOGY LETTERS (2012)
Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice
Tobie D. Wolfe et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
Catherine H. Van Poznak et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Synthesis, characterization, and preliminary assessment of anti-Flt1 peptide-hyaluronate conjugate for the treatment of corneal neovascularization
Eun Ju Oh et al.
BIOMATERIALS (2009)
Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model
Kazutaka Koto et al.
CANCER LETTERS (2009)
Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model
Agatha Labrinidis et al.
CLINICAL CANCER RESEARCH (2009)
Emerging robe of bisphosphonates in the clinic - Antitumor activity and prevention of metastasis to bone
Allan Lipton
CANCER TREATMENT REVIEWS (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Zoledronic acid inhibits osteosarcoma growth in an orthotopic model
Crispin R. Dass et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells
M. Muraro et al.
CELLULAR IMMUNOLOGY (2007)
Share Paper
